Titre :
|
Evaluation of a Cervical Cancer Control Intervention Using Lay Health Workers for Vietnamese American Women. (2010)
|
Auteurs :
|
Victoria-M TAYLOR ;
Elizabeth ACORDA ;
JACKSON (Jcarey) : USA. Department of Medicine. University of Washington. Seattle. ;
. LIN LI ;
NGUYEN (Tung-T) : USA. Department of Medicine. University of California. San Francisco. ;
Scott RAMSEY ;
Erica WOODALL ;
YASUI (Yutaka) : CAN. Department of Public Health Sciences. University of Alberta. Edmonton.
|
Type de document :
|
Article
|
Dans :
|
American journal of public health (vol. 100, n° 10, 2010)
|
Pagination :
|
1924-1929
|
Langues:
|
Anglais
|
Mots-clés :
|
Cancer
;
Evaluation
;
Contrôle
;
Surveillance
;
Projet loi
;
Vietnam
;
Femme
;
Asie
;
Homme
;
Amérique
;
Amérique du Nord
|
Résumé :
|
[BDSP. Notice produite par INIST-CNRS DHE8R0xs. Diffusion soumise à autorisation]. Objectives. We conducted a trial to evaluate the effectiveness of a cervical cancer control intervention for Vietnamese American women that used lay health workers. Methods. The study group included 234 women who had not received a Papanicolaou (Pap) test in the last 3 years. Experimental group participants received a lay health worker home visit. Our trial endpoint was Pap test receipt within 6 months of randomization. Pap testing completion was ascertained through women's self-reports and medical record reviews. We examined intervention effects among women who had ever received a Pap test (prior to randomization) and women who had never received a Pap test. Results. Three quarters of the women in the experimental group completed a home visit. Ever-screened experimental group women were significantly more likely to report Pap testing (P<. 02) and to have records verifying Pap testing (P<. 04) than were ever-screened control group women. There were no significant differences between the trial arms for women who had never been screened. Conclusions. Our findings indicate that lay health worker-based interventions for Vietnamese American women are feasible to implement and can increase levels of Pap testing use among ever-screened women but not among never-screened women.
|